Bioequivalence Study Clinical Trial
Official title:
Single-dose, Open-label, Randomized, 2-way Crossover Bioequivalence Study of Gefitinib Tablets Under Fasting Conditions in Chinese Healthy Male Subjects
The study design is an Open-Label，Randomized, Single-Dose, 2-way Crossover Bioequivalence Study. During each session, the subjects will be administered a single dose of 250mg Gefitinib Tablet (one Gefitinib Tablet 250mg of Hunan Kelun or one Iressa® Tablet 250mg of AstraZeneca) under fasting conditions.
An Open-Label，Randomized, Single-Dose, 2-way Crossover Bioequivalence Study. During each session, the subjects were randomly assigned in a 1:1 ratio to receive a single 250-mg dose of either the test formulation(Hunam Kelun) or the reference formulation(Iressa® Astrazeneca), and vice versa, with a 21-day washout period between administration periods. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06441916 -
Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions
|
Phase 1 | |
| Completed |
NCT04877834 -
Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.
|
Phase 1 | |
| Not yet recruiting |
NCT06058689 -
A Pilot Bioequivalence Study of Pomalidomide
|
Phase 1 | |
| Completed |
NCT05436769 -
Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet
|
Phase 1 | |
| Completed |
NCT04585321 -
Comparative Bioavailability and Local Tolerability of Two Topical Diclofenac Plasters Applied Once and Twice a Day
|
Phase 1 | |
| Completed |
NCT04873570 -
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
|
Phase 1 | |
| Completed |
NCT01595425 -
Bioequivalence Study Comparing D961H Sachet and D961H Capsule in Japanese Healthy Male Subjects
|
Phase 1 | |
| Recruiting |
NCT05794919 -
Bioequivalence Study of Calcium Hydroxybenzene Sulphonate Dispersible Tablets in Chinese Healthy Volunteers
|
N/A | |
| Completed |
NCT04358770 -
Bio-equivalence Vasoconstriction Activity Study for Topically Applied Clocortolone Pivalate 0.1% Cream
|
Phase 1 | |
| Completed |
NCT03602300 -
A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study
|
Phase 1 | |
| Completed |
NCT05436886 -
Bioequivalence Study of Neurogabin-M (Gabapentin 400 mg) Capsule With Parketin (Gabapentin 400 mg) Capsules
|
N/A | |
| Completed |
NCT01494402 -
Study to Assess the Bioequivalence Between D961S and Esomeprazole/Buffered Acetylsalicylic Acid (ASA) in Japanese Healthy Male Subjects
|
Phase 1 | |
| Recruiting |
NCT04229602 -
Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers
|
N/A | |
| Completed |
NCT03765944 -
Bioequivalence Study of NPC-12 (Sirolimus) Granules and Tablets
|
Phase 1 | |
| Not yet recruiting |
NCT06273254 -
A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions
|
Phase 1 |